Product

Treprostinil diethanolamine

Aliases

treprostinil diethanolamine, UT-15C Sustained Release (SR)

3 clinical trials

3 indications

Indication

systemic sclerosis

Indication

Indication

Pulmonary Arterial Hypertension

Clinical trial

DISTOL-1: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: A Randomized, Double-blind, Placebo-controlled, Multicenter Study

Status: Completed, Estimated PCD: 2011-03-01

Clinical trial

A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15C SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol

Status: Completed, Estimated PCD: 2013-11-01

Clinical trial

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study

Status: Terminated, Estimated PCD: 2011-09-01